glp-1 alzheimer's study Could diabetes and weight loss drugs treat disease? GLP-1R agonists protect against Alzheimer's

Navigating the B(12) road: assimilation, delivery, and disorders of cobalamin

Synergic integration of the miRNome, machine learning and Bioinformatics for the identification of potential disease-modifying agents in Obstructive Sleep Apnea

and Mills, K.A., 1995

Why receptor subtype work matters for interpretation A common question is which receptor subtype is doing the work. A 2025 mechanistic study investigated AMY receptor subtype dependence and reported that cagrilintides body weight lowering effects depended on AMY1R and AMY3R in their models, which provides a more concrete receptor anchored explanation than general appetite language

Financing: Payment plans are provided by third-party lenders and subject to their approval processes and terms